Skip to main content
logo
Leggett & Platt, Incorporated (LEG)
NYSE: LEG · Real-Time Price · USD
8.08
-1.47 (-15.39%)
At close: Aug 1, 2025, 4:00 PM
8.22
+0.14 (1.73%)
After-hours: Aug 1, 2025, 7:00 PM EDT

Revance Therapeutics Revenue

Leggett & Platt had revenue of $1.06B in the quarter ending June 30, 2025, a decrease of -6.26%. This brings the company's revenue in the last twelve months to $4.24B, down -6.15% year-over-year. In the year 2024, Leggett & Platt had annual revenue of $4.38B, down -7.23%.

Revenue (ttm)
$4.24B
Revenue Growth
-6.15%
P/S Ratio
0.26
Revenue / Employee
$239,446
Employees
17,700
Market Cap
1.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20244.38B-341.70M-7.23%
Dec 31, 20234.73B-421.40M-8.19%
Dec 31, 20225.15B74.10M1.46%
Dec 31, 20215.07B792.40M18.51%
Dec 31, 20204.28B-472.30M-9.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Amazon.com650.31B
Toyota Motor320.78B
The Home Depot162.95B
Alibaba Group Holding137.30B
Tesla92.72B
Lowe's Companies83.24B
The TJX Companies56.99B
PDD Holdings55.49B
Revenue Rankings

LEG News

More News